Advanced search
Publication Cover
Journal of Obstetrics and Gynaecology Volume 42, 2022 - Issue 1
Submit an article Journal homepage
267
Views
3
CrossRef citations to date
0
Altmetric
Original Articles: Gynaecology

Cabergoline versus calcium infusion in the prevention of ovarian hyperstimulation syndrome: a randomised controlled study

Usama M. Foudaa Department of Obstetrics and Gynecology, Faculty of Medicine, Cairo University, Cairo, EgyptCorrespondence[email protected]
,
Hesham S. Elshaera Department of Obstetrics and Gynecology, Faculty of Medicine, Cairo University, Cairo, Egypt
,
Gamal G. Youssefa Department of Obstetrics and Gynecology, Faculty of Medicine, Cairo University, Cairo, Egypt
,
Amal Hanafya Department of Obstetrics and Gynecology, Faculty of Medicine, Cairo University, Cairo, Egypt
,
Waleed M. Mehremb Assisted Conception Unit, Al Gazeera Hospital, Giza, Egypt
,
Mohamed A. Youssefa Department of Obstetrics and Gynecology, Faculty of Medicine, Cairo University, Cairo, Egypt
,
Mona Farouka Department of Obstetrics and Gynecology, Faculty of Medicine, Cairo University, Cairo, Egypt
&
Hala Nabila Department of Obstetrics and Gynecology, Faculty of Medicine, Cairo University, Cairo, Egypt
 show all
Pages 122-126 | Published online: 16 Jul 2021

References

  • Ando H, Furugori K, Shibata D, Harata T, Murata Y, Mizutani S. 2003. Dual renin–angiotensin blockade therapy in patients at high risk of early ovarian hyperstimulation syndrome receiving IVF and elective embryo cryopreservation: a case series. Human Reproduction (Oxford, England) 18:1219–1222.
  • Ata B, Yakin K, Alatas C, Urman B. 2008. Dual renin–angiotensin blockage and total embryo cryopreservation is not a risk-free strategy in patients at high risk for ovarian hyperstimulation syndrome. Fertility and Sterility 90:531–536.
  • Baumgarten M, Polanski L, Campbell B, Raine-Fenning N. 2013. Do dopamine agonists prevent or reduce the severity of ovarian hyperstimulation syndrome in women undergoing assisted reproduction? A systematic review and meta-analysis. Human Fertility (Cambridge, England) 16:168–174.
  • Beierwaltes WH. 2010. The role of calcium in the regulation of renin secretion. American Journal of Physiology. Renal Physiology 298:F1–F11.
  • Carbajo-Lozoya J, Lutz S, Feng Y, Kroll J, Hammes HP, Wieland T. 2012. Angiotensin II modulates VEGF-driven angiogenesis by opposing effects of type 1 and type 2 receptor stimulation in the microvascular endothelium. Cellular Signalling 24:1261–1269.
  • El-Khayat W, Elsadek M. 2015. Calcium infusion for the prevention of ovarian hyperstimulation syndrome: a double-blind randomized controlled trial. Fertility and Sterility 103:101–105.
  • Ferrero H, García-Pascual CM, Pellicer N, Simón C, Pellicer A, Gómez R. 2015. Dopamine agonist inhibits vascular endothelial growth factor protein production and secretion in granulosa cells. Reproductive Biology and Endocrinology : RB&E 13:104.
  • Fouda UM, Sayed AM, Elshaer HS, Hammad BE, Shaban MM, Elsetohy KA, et al. 2016. GnRH antagonist rescue protocol combined with cabergoline versus cabergoline alone in the prevention of ovarian hyperstimulation syndrome: a randomized controlled trial. Journal of Ovarian Research 9:29.
  • Fouda UM, Sayed AM. 2011. Extended high dose letrozole regimen versus short low dose letrozole regimen as an adjuvant to gonadotropin releasing hormone antagonist protocol in poor responders undergoing IVF-ET. Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology 27:1018–1022.
  • Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Caspi E. 1989. Ovarian hyperstimulation syndrome: an update review. Obstetrical & Gynecological Survey 44:430–440.
  • Gurgan T, Demirol A, Guven S, Benkhalifa M, Girgin B, Li TC. 2011. Intravenous calcium infusion as a novel preventive therapy of ovarian hyperstimulation syndrome for patients with polycystic ovarian syndrome. Fertility and Sterility 96:53–57.
  • Herr D, Duncan WC, Hack G, Konrad R, Kreienberg R, Wulff C. 2010. Regulated expression of the renin–angiotensin-system in human granulosa lutein cells: angiotensin II increases VEGF expression but its synthesis is reduced by hCG. Archives of Gynecology and Obstetrics 281:409–416.
  • Kumar P, Sait SF, Sharma A, Kumar M. 2011. Ovarian hyperstimulation syndrome. Journal of Human Reproductive Sciences 4:70–75.
  • Leitao VM, Moroni RM, Seko LM, Nastri CO, Martins WP. 2014. Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials. Fertility and Sterility 101:664–675.
  • Morris RS, Wong IL, Kirkman E, Gentschein E, Paulson RJ. 1995. Inhibition of ovarian-derived prorenin to angiotensin cascade in the treatment of ovarian hyperstimulation syndrome. Human Reproduction (Oxford, England) 10:1355–1358.
  • Naredi N, Karunakaran S. 2013. Calcium gluconate infusion is as effective as the vascular endothelial growth factor antagonist cabergoline for the prevention of ovarian hyperstimulation syndrome. Journal of Human Reproductive Sciences 6:248–252.
  • Palumbo A, Ávila J, Naftolin F. 2016. The ovarian renin–angiotensin system (OVRAS): a major factor in ovarian function and disease. Reproductive Sciences (Thousand Oaks, Calif.) 23:1644–1655.
  • Şahin Y, Kontaş O, Müderris II, Cankurtaran M. 1997. Effects of angiotensin converting enzyme inhibitor cilazapril and angiotensin II antagonist saralasin in ovarian hyperstimulation syndrome in the rabbit. Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology 11:231–236.
  • Tang T, Glanville J, Orsi N, Barth JH, Balen AH. 2006. The use of metformin for women with PCOS undergoing IVF treatment. Human Reproduction (Oxford, England) 21:1416–1425.
  • Yakovenko SA, Sivozhelezov VS, Zorina IV. 2009. Prevention of OHSS by intravenous calcium. Human Reproduction 24:i61.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.